A good night’s sleep has always been linked to better mood, and better health. Now, scientists have even more evidence of just how much sleep – and more specifically our circadian rhythm, which regulates our sleep cycle – is linked to certain diseases, such as Alzheimer’s disease. A team of researchers from the United States…
Link Between Sugar and Alzheimer’s Strengthens
Alzheimer’s disease — for which conventional medicine believes there is no effective treatment or cure — currently affects an estimated 5.4 million Americans and prevalence is projected to triple by 2050. Within the next two decades, this severe and lethal form of dementia may affect as much as one-quarter of the U.S. population. Already, more than half…
Biogen Slumps After Medicare’s Restrictive Decision on Alzheimer’s Drug
Shares of Biogen Inc fell nearly 10 percent on Wednesday after the U.S. government announced limited coverage of Alzheimer’s treatments including the drugmaker’s Aduhelm, dealing a blow to the controversial treatment that was approved last year. Biogen had been banking on the government’s coverage decision to help drive up sales of Aduhelm, which it hoped…
Link Between Alzheimer’s and Gut Is Confirmed
Alzheimer’s disease continues to be a leading cause of death in the U.S., with 1 in 3 seniors dying with Alzheimer’s or dementia — more than the number killed by breast and prostate cancers combined. While a cure has remained elusive, the connection between brain health and gut microbiota has grown clearer, and research suggests…
Biogen, Eisai Alzheimer’s Drug Lecanemab Gets ‘Fast Track’ Designation From FDA
Biogen Inc. and Japanese partner Eisai Co. said on Thursday the U.S. Food and Drug Administration (FDA) had granted “fast track” designation to their experimental therapy lecanemab for the treatment of early Alzheimer’s disease. The FDA had granted “breakthrough” therapy designation to the drug earlier this year. The drug works in a similar manner to…
Biogen Halves Price of Alzheimer’s Drug to $28,200
Biogen Inc. on Monday cut the price of its Alzheimer’s drug by about half to $28,200 for an average weight person after facing slower-than-expected U.S. sales on complaints from hospitals that its high cost was not worth its benefits. The U.S. Food and Drug Administration (FDA) approved the drug, Aduhelm, in June to treat the…
Meet the 81-Year-Old Climbing Scottish Mountains for His Sick Wife
BALLACHULISH, Scotland—At the windswept summit of Buachaille Etive Mòr, a Scottish peak more than 3,350 ft)above sea level, 81-year-old Nick Gardner stops to gaze down at the rugged peaks, lochs, and valleys visible through the drifting clouds. “It’s so exciting every time I still feel like a little boy,” he said. “I need my hat…
FDA Head Calls for Probe Into Alzheimer’s Drug Review
WASHINGTON—The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug. Dr. Janet Woodcock announced the extraordinary step via Twitter. It’s the latest fallout over last month’s approval of Aduhelm, an expensive…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`